tykhr
sign in
free sign up
Inovio Pharmaceuticals Inc
Biotechnology
Healthcare
INO
38.83 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.49
52 week high
6.82
high
2.51
52 week low
0.00
low
2.37
growth
-62.81 %
previous Close
2.49
P/E ratio
market cap
75.93 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-23.52 B
-119.00 %
eps
0.00 %
-19.61 %
eps surprise
1.29 %
net profit margin
-2351941200000.00 %
30140.00 %
operating incoming
-23.08 B
-92.00 %
net change in cash
-15.56 B
39.90 %
cash on hand
24.35 B
-38.99 %
cost of revenue
0.00 %
top